NZ626736A - Phragamalin limonoids for the treatment of sexual dysfunction - Google Patents

Phragamalin limonoids for the treatment of sexual dysfunction

Info

Publication number
NZ626736A
NZ626736A NZ626736A NZ62673613A NZ626736A NZ 626736 A NZ626736 A NZ 626736A NZ 626736 A NZ626736 A NZ 626736A NZ 62673613 A NZ62673613 A NZ 62673613A NZ 626736 A NZ626736 A NZ 626736A
Authority
NZ
New Zealand
Prior art keywords
compounds
phragamalin
limonoids
treatment
sexual dysfunction
Prior art date
Application number
NZ626736A
Other languages
English (en)
Inventor
Jarl Wikberg
Aigars Jirgensons
Edvards Liepinsh
Original Assignee
Dicotyledon Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dicotyledon Ab filed Critical Dicotyledon Ab
Publication of NZ626736A publication Critical patent/NZ626736A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ626736A 2012-01-25 2013-01-25 Phragamalin limonoids for the treatment of sexual dysfunction NZ626736A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE1200052 2012-01-25
SE1200678 2012-11-06
SE1300011 2013-01-04
PCT/EP2013/051413 WO2013110744A2 (en) 2012-01-25 2013-01-25 Novel compounds, their manufacture and uses (ii)

Publications (1)

Publication Number Publication Date
NZ626736A true NZ626736A (en) 2016-11-25

Family

ID=47666104

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ626736A NZ626736A (en) 2012-01-25 2013-01-25 Phragamalin limonoids for the treatment of sexual dysfunction

Country Status (11)

Country Link
US (1) US9403841B2 (enExample)
EP (1) EP2807170B1 (enExample)
CN (1) CN104254537B (enExample)
AU (1) AU2013213580B2 (enExample)
CA (1) CA2861045A1 (enExample)
DK (1) DK2807170T3 (enExample)
ES (1) ES2723248T3 (enExample)
IN (1) IN2014DN05615A (enExample)
NZ (1) NZ626736A (enExample)
PL (1) PL2807170T3 (enExample)
WO (1) WO2013110744A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104628692B (zh) * 2015-02-09 2016-02-10 庄爱华 柠檬苦素类化合物,其药物组合物及其制备方法和用途
CN208336488U (zh) * 2015-07-31 2019-01-04 株式会社村田制作所 线圈天线以及天线装置
CN109394732A (zh) * 2017-08-16 2019-03-01 安徽中医药大学 盐酸青藤碱肠溶定位渗透泵控释胶囊及其制备方法
CN110903912B (zh) * 2019-11-29 2022-01-28 华东理工大学 一种芳基油脂及其制备方法与应用
CN111755072B (zh) * 2020-08-04 2021-02-02 深圳吉因加医学检验实验室 一种同时检测甲基化水平、基因组变异和插入片段的方法及装置
CN112898263B (zh) * 2021-01-28 2022-03-08 江西中医药大学 一种从佛手中分离的香豆素骈木脂素化合物及其保肝用途
SE2251130A1 (en) * 2022-09-30 2024-03-31 Dicot Ab New compounds and methods of their manufacturing
WO2025040810A1 (en) 2023-08-23 2025-02-27 Dicot Pharma Ab Therapeutic compounds, a method of manufacturing thereof as well as uses thereof
WO2025141142A1 (en) * 2023-12-29 2025-07-03 Dicot Pharma Ab A novel method for recovering limonoid compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1318825A2 (de) 2000-07-26 2003-06-18 Vitaplant AG Piper methysticum pflanzenextrakt
CN1226298C (zh) * 2003-08-07 2005-11-09 中国科学院南海海洋研究所 柠檬苦素化合物-木果楝内酯及其用途
JP2005213202A (ja) 2004-01-29 2005-08-11 Maruzen Pharmaceut Co Ltd 抗酸化剤、抗老化剤及び抗炎症剤、並びに、皮膚化粧料
CA2623831A1 (en) 2005-09-12 2007-03-22 Council Of Scientific And Industrial Research An extract from xylocarpus useful for the treatment of diabetes and dyslipidemia
AU2008256521B2 (en) 2007-05-29 2014-09-04 Dicot Ab Novel compounds and pharmaceutical preparations from Neobeguea spec
GB0710230D0 (en) 2007-05-30 2007-07-11 Reckitt Benckiser Nv Detergent dosing device
US7786171B2 (en) 2008-04-04 2010-08-31 Abbott Laboratories Amide derivatives as positive allosteric modulators and methods of use thereof

Also Published As

Publication number Publication date
AU2013213580B2 (en) 2017-06-15
EP2807170A2 (en) 2014-12-03
CA2861045A1 (en) 2013-08-01
DK2807170T3 (da) 2019-05-27
AU2013213580A1 (en) 2014-07-24
EP2807170B1 (en) 2019-03-13
US20150011616A1 (en) 2015-01-08
ES2723248T3 (es) 2019-08-22
IN2014DN05615A (enExample) 2015-04-03
PL2807170T3 (pl) 2019-09-30
CN104254537A (zh) 2014-12-31
WO2013110744A2 (en) 2013-08-01
CN104254537B (zh) 2017-06-30
HK1204325A1 (en) 2015-11-13
WO2013110744A3 (en) 2013-10-31
US9403841B2 (en) 2016-08-02

Similar Documents

Publication Publication Date Title
NZ626736A (en) Phragamalin limonoids for the treatment of sexual dysfunction
PH12018501839A1 (en) St2l antagonists and methods of use
PH12014501164A1 (en) Anti-cd98 antibodies and methods of use thereof
MX2014011134A (es) Compuestos de carbamato y preparacion y uso de los mismos.
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
JO2860B1 (en) Phenylendazolyl compounds
HK1220980A1 (zh) 用於治疗庞贝氏症的方法和组合物
PH12014502601A1 (en) ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
GB2538178A (en) Viscosifier polymer for treatment of a subterranean formation
MX2013011479A (es) Anticuerpos anti-fgfr4 y metodos de uso.
EA201400178A1 (ru) Лечение рака молочной железы
PH12014500841B1 (en) ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
PH12014501605A1 (en) Anti-lrp5 antibodies and methods of use
MX2016003823A (es) Inhibidor selectivo de fosfatidil-inositol 3-cinasa-gamma.
MX354303B (es) Anticuerpos de anti-biotina y metodos de uso.
MX2014004074A (es) Metodo de tratamiento de condiciones del higado utilizando antagonistas de notch2.
PH12015501627A1 (en) Kv1.3 antagonists and methods of use
PH12014500925A1 (en) Therapeutic combinations and methods of treating melanoma
MX357675B (es) Anticuerpos anti-jagged y métodos de uso.
MX2016009655A (es) Metodos novedosos para el tratamiento del cancer.
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
EA201690709A1 (ru) Применение одипарцила в лечении мукополисахаридоза
UA70225U (ru) Применение композиции, содержащей мирамистин, в качестве лекарственного средства для лечения заболеваний горла
LV14779A (lv) 4-Amino-2-(1,2,3-triazol-1-il)-hinazolīna atvasinājumi un to sintēzes paņēmiens

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 25 JAN 2020 BY GRIFFITH HACK

Effective date: 20170309

ASS Change of ownership

Owner name: DICOT AB, SE

Effective date: 20180515

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 JAN 2021 BY CPA GLOBAL (PATRAFEE) AB

Effective date: 20200117

LAPS Patent lapsed